
|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
almost 14 years ago
Emerging Pharma Leaders 2012almost 14 years ago
Who Will Pay for New Drugs?almost 14 years ago
Less, But Betteralmost 14 years ago
John Lechleiter on PhRMA and Innovationalmost 14 years ago
Today's Mission Critical: Making Sense of Spending on Clinical Trialsalmost 14 years ago
The Learning Curvealmost 14 years ago
Marketing: Why the Conversation Has Changed — ForeverNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Aradhana Sarin: The CFO as a Catalyst
2
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
3
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
4
Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB
5



